Clinical considerations for critically ill COVID-19 cancer patients: A systematic review

doi:10.12998/wjcc.v9.i28.8441

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5244)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-1) series.

Item

Count

PDF

419

WORD

168

HTML

2848

Figures (1-4)

245

Tables (1-1)

229

Sum=3909

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

468

Download

867

Sum=1335

Oct 6, 2021 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Clin Cases. Oct 6, 2021; 9(28): 8441-8452
Published online Oct 6, 2021. doi: 10.12998/wjcc.v9.i28.8441

Full Size Figure Download Figure

Figure 4 Contributors of worse outcome of among cancer patients with coronavirus disease 2019 infection. ¹Higher levels of C-reactive protein, D-dimer, ferritin and procalcitonin.

Citation: Ramasamy C, Mishra AK, John KJ, Lal A. Clinical considerations for critically ill COVID-19 cancer patients: A systematic review. World J Clin Cases 2021; 9(28): 8441-8452
URL: https://www.wjgnet.com/2307-8960/full/v9/i28/8441.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i28.8441